Pulmonary Hypertension Program

Pulmonary Hypertension Program Overview

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Pulmonary Hypertension ProgramFortunately, there is a lot of good news to share about pulmonary hypertension, a condition in which blood pressure in the arteries of the lungs (the pulmonary arteries) is abnormally high. A little more than a decade ago, doctors’ understanding of this condition was crude, and effective therapy was more of a hope than a reality. But thanks to advances in basic science and clinical research, much better therapies have been developed, and nearly every year brings new treatments for this disorder.

The Pulmonary Hypertension Program at Boston Children’s Hospital is one of the leading pulmonary hypertension programs in the United States.

What is pulmonary hypertension?

Pulmonary hypertension is a condition in which blood pressure in the arteries of the lungs (the pulmonary arteries) is abnormally high. As the pressure builds, your heart's right ventricle has to work harder to pump blood through your lungs. This eventually causes your heart muscle to weaken and eventually fail completely.

Unlike other congenital heart conditions, there is no surgical treatment or “cure” for pulmonary hypertension. But treatments are available that can help lessen symptoms and improve your child’s quality of life.

Learn more about pulmonary hypertension and how Boston Children’s cares for children with pulmonary hypertension.

Our services and expertise

Our program provides comprehensive diagnosis and individualized treatment plans for children and adults with pulmonary hypertension (PH).

Managing pulmonary hypertension requires the combined expertise of many specialists. Our team includes cardiologists, radiologists and pulmonologists who are experts in PH, as well as specially trained nurses who provide helpful assistance and support for families. With particularly difficult cases, we do not hesitate to consult with experts at other hospitals. Our goal is to provide the best care possible to our patients.

Advancing our understanding of PH

Researchers at Boston Children's are studying how to prevent and treat pulmonary hypertension. We have participated in prospective trials of inhaled nitric oxide, sildenafil, bosentan and ambrisentan. Current therapeutic trials include evaluation of a new, more efficient way of delivering inhaled iloprost, and a study of the long-term effects of sildenafil and ambrisentan.

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
More optionsSearch
Condition & Treatments
Search for a Condition or Treatment:
View allSearch
Visitor Information

Visit the Heart Center Facebook community today!

Donate to Boston Children's

Support Boston Children's Heart Center

Contact the Pulmonary Hypertension Program

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO